Go to the list of all blogs
AI dvisor's Avatar
published in Blogs
Nov 19, 2026
TickeronGET DAILY SIGNALS
ABG vs BBWI: Asbury's Completed Tech Rollout Against Bath & Body Works' Ongoing Turnaround

ABG vs BBWI: Asbury's Completed Tech Rollout Against Bath & Body Works' Ongoing Turnaround

Key Takeaways

  • ABG (Asbury Automotive Group) finished its company-wide technology platform rollout and saw shares move higher after its most recent earnings, while BBWI (Bath & Body Works) continues working through a multi-year turnaround marked by declining same-store sales.
  • Asbury's relative strength has been helped by better used-vehicle margins and an efficiency-focused catalyst narrative, whereas Bath & Body Works faces pressure from soft holiday-quarter guidance.
  • Tickeron AI Verdict: ABG — trend consistency and fresh operational catalysts currently favor Asbury Automotive Group over Bath & Body Works.
  • For additional background on each name, check ABG Major News and ABG Today's Price Move, as well as BBWI Major News and BBWI Today's Price Move.
  • To see how AI-driven strategies are positioned in the market, visit Trending AI Robots.

Setting the Stage: Two Different Consumer Plays

This comparison lines up two distinct consumer-facing businesses: Asbury Automotive Group, a major U.S. automotive retailer, and Bath & Body Works, a specialty retailer focused on soaps, fragrances, and home-care items. Both sit in cyclical, discretionary categories, yet their current positions look quite different. Asbury is coming out of a major technology integration with an emphasis on margin recovery, while Bath & Body Works is pushing a brand-led turnaround amid softer store traffic. Traders and investors looking at relative performance, momentum, and catalysts may find this side-by-side look helpful.

Asbury Automotive Group: Tech Integration Complete

Asbury Automotive Group (ABG) operates more than 150 new-vehicle dealerships across the United States, along with collision repair centers and its Total Care Auto service-contract business. In recent weeks the stock has moved on a clear catalyst: the full rollout of the Tekion dealer management software platform now live in every store. Management has described this as a milestone that frees up resources to focus on running and growing the business. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

The latest quarterly results showed revenue down year over year due to softer new-vehicle economics, yet the market reacted positively and shares rose after the release. Investors have highlighted improving used-vehicle gross profit, early efficiency gains in the longest-running Tekion stores, and a clear plan to lower SG&A as a percentage of gross profit through 2027. On the other side, net leverage remains elevated and management is working to bring it down, while near-term margins still face some pressure from the integration itself.

Bath & Body Works: Navigating the Turnaround

Bath & Body Works (BBWI) sells body care, home fragrance, soaps, and sanitizers through roughly 1,900 company-operated stores, a growing digital channel, and wholesale partners including Amazon and Ulta Beauty. The company is in the early phase of its “Consumer First Formula” strategy aimed at rebuilding brand relevance and returning to sustainable growth.

Recent results have been mixed. The most recent quarter delivered a modest sales beat and adjusted EPS above guidance, and management raised its full-year sales outlook while authorizing a new share repurchase program. At the same time, North American same-store sales stayed negative and holiday-quarter guidance pointed to a meaningful year-over-year earnings decline. Sentiment has reflected this balance between progress in digital and wholesale channels and continued softness in the core store base.

Side-by-Side: Momentum, Risks, and Sector Exposure

The two companies serve different parts of consumer discretionary spending. Asbury draws revenue from vehicle sales, parts and service, and finance and insurance, which gives it a steadier service component alongside the cyclical vehicle-sales engine. Bath & Body Works runs a branded retail model with strong gross margins but heavy reliance on the holiday season and physical-store traffic.

On momentum, Asbury shows the clearer near-term setup with a finished technology rollout, early efficiency evidence, and a favorable market reaction to its latest report. Bath & Body Works faces a more difficult tape, with negative same-store sales and cautious guidance offsetting gains in newer channels. Risk profiles differ as well: Asbury carries meaningful balance-sheet leverage from past acquisitions, while Bath & Body Works deals with a shrinking core store base and margin pressure from tariffs and promotions. Sector exposure further separates them—Asbury tracks the automotive cycle and interest rates, while Bath & Body Works ties more directly to discretionary consumer spending and seasonal retail demand.

Where AI Points on These Names

Based on the factors in view, Tickeron’s AI currently leans toward ABG. Asbury offers a more coherent catalyst path—a completed integration, better used-vehicle profitability, and a defined efficiency plan—along with a positive earnings reaction. Bath & Body Works, while trading at a lower valuation and showing incremental progress in new channels, still faces declining same-store sales and cautious holiday guidance that leaves its trend less consistent. This view reflects trend consistency, relative positioning, and catalyst visibility rather than any assurance of future results.

Using Tickeron AI Tools in My Research

I often turn to Tickeron’s Trending AI Robots when comparing names like these. The page highlights a selection of automated strategies that trade thousands of tickers, letting me quickly compare performance profiles and see which bots are best suited to current conditions for stocks such as ABG and BBWI. It provides a practical way to understand how systematic approaches are positioned without having to build the models myself.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ABG, BBWI

ABG in upward trend: 10-day moving average crossed above 50-day moving average on November 04, 2026

The 10-day moving average for ABG crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 19 of 24 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

ABG moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +12.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where ABG advanced for three days, in 218 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

The Aroon Indicator entered an Uptrend today. In 122 of 193 cases where ABG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.

Bearish Trend Analysis

The 10-day RSI Indicator for ABG moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 26 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 81%.

The Momentum Indicator moved below the 0 level on November 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ABG as a result. In 61 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 66%.

The Moving Average Convergence Divergence Histogram (MACD) for ABG turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 34 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

ABG broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. ABG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 48 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 52 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.927) is normal, around the industry mean (1.554). P/E Ratio (7.528) is within average values for comparable stocks, (12.811). Projected Growth (PEG Ratio) (0.449) is also within normal values, averaging (0.695). Dividend Yield (0.004) settles around the average of (0.011) among similar stocks. P/S Ratio (0.207) is also within normal values, averaging (0.919).

The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

Industry description

The Automotive Aftermarket consists of the manufacturing, remanufacturing, distribution, retailing, and installation of vehicle parts and accessories, after the sale of the automobile by the original equipment manufacturer (OEM) to the consumer. The aftermarket parts many not be manufactured by the OEM. According to a Technavio study, the US automotive parts aftermarket size is estimated to grow by USD 24.33 billion during 2018-2022 (CAGR 3%). Like many other industries, the automotive aftermarket is also being intensely penetrated by the digital boom. The online auto parts sales market is predicted to exceed $13B by 2020 (according to a study by Mirakl).

Market Cap

The average market capitalization across the Automotive Aftermarket Industry is 4.76B. The market cap for tickers in the group ranges from 1.57M to 52.96B. CVNA holds the highest valuation in this group at 52.96B. The lowest valued company is GORV at 1.57M.

High and low price notable news

The average weekly price growth across all stocks in the Automotive Aftermarket Industry was -3%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -20%. AZI experienced the highest price growth at 62%, while SDA experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the Automotive Aftermarket Industry was 33%. For the same stocks of the Industry, the average monthly volume growth was 45% and the average quarterly volume growth was 13%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 55
Price Growth Rating: 65
SMR Rating: 76
Profit Risk Rating: 83
Seasonality Score: 15 (-100 ... +100)
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an operator of an automotive retailers

Industry AutomotiveAftermarket

Industry
Specialty Stores
Address
6655 Peachtree Dunwoody Road
Phone
+1 770 418-8200
Employees
15000
Web
https://www.asburyauto.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.
KLAR dropped -4.84% to $13.75 from Wednesday's close of $14.45, with the decline occurring during Thursday's regular session. JPMorgan downgraded the shares to Hold from Overweight and cut its price target to $17 from $20 in a note published before the open, extending a run of post-earnings target reductions.